CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, John P. Reilly, Nicholas Han et al.|Nature Medicine|2021Cited by 519
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trialKim A. Reiss, Robert H. Vonderheide, Thomas B. Karasic et al.|The Lancet Oncology|2022Cited by 137
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal CancerThomas B. Karasic, Peter J. O’Dwyer, Timothy J. Brown et al.|The Oncologist|2022Cited by 33